The University of Chicago Header Logo

Connection

Issam Awad to Male

Back to Details
This is a "connection" page, showing publications Issam Awad has written about Male.
Issam Awad
Connection Strength
1.622
Male
  1. Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. J Am Heart Assoc. 2026 02 03; 15(3):e46943.
    View in: PubMed
    Score: 0.045
  2. Relevance of Lesion Volume as an Outcome in Cerebral Cavernous Malformation Drug Trial: Exploratory Analyses in Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept. Neurosurgery. 2026 Jun 01; 98(6):1395-1401.
    View in: PubMed
    Score: 0.045
  3. Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study. J Neurosurg. 2025 Dec 01; 143(6):1567-1574.
    View in: PubMed
    Score: 0.044
  4. Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
    View in: PubMed
    Score: 0.043
  5. Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2025 06; 45(6):1153-1165.
    View in: PubMed
    Score: 0.042
  6. Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations. Transl Stroke Res. 2025 Jun; 16(3):859-867.
    View in: PubMed
    Score: 0.041
  7. COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106101.
    View in: PubMed
    Score: 0.034
  8. Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
    View in: PubMed
    Score: 0.033
  9. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
    View in: PubMed
    Score: 0.032
  10. Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.032
  11. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168.
    View in: PubMed
    Score: 0.029
  12. Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268.
    View in: PubMed
    Score: 0.028
  13. Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening. J Neurosurg. 2018 10; 129(4):954-960.
    View in: PubMed
    Score: 0.026
  14. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866.
    View in: PubMed
    Score: 0.026
  15. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
    View in: PubMed
    Score: 0.025
  16. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018 04; 47(4):1133-1138.
    View in: PubMed
    Score: 0.025
  17. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
    View in: PubMed
    Score: 0.024
  18. Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease. J Neurosci Methods. 2016 09 15; 271:14-24.
    View in: PubMed
    Score: 0.023
  19. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models. J Neuroimmune Pharmacol. 2016 06; 11(2):369-77.
    View in: PubMed
    Score: 0.023
  20. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol. 2016 Jul; 37(7):1209-15.
    View in: PubMed
    Score: 0.023
  21. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016; 10(3):255-64.
    View in: PubMed
    Score: 0.023
  22. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1632-9.
    View in: PubMed
    Score: 0.022
  23. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014 Jul 15; 272(1-2):67-75.
    View in: PubMed
    Score: 0.020
  24. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014 Feb; 45(2):598-601.
    View in: PubMed
    Score: 0.020
  25. Intensive care after elective craniotomy: "all politics is local". World Neurosurg. 2014 Jan; 81(1):64-5.
    View in: PubMed
    Score: 0.018
  26. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4.
    View in: PubMed
    Score: 0.018
  27. A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective? Hematol Oncol Stem Cell Ther. 2012; 5(1):36-41.
    View in: PubMed
    Score: 0.017
  28. Fatal "hypertensive" intracerebral hemorrhage associated with a cerebral cavernous angioma: case report. Acta Neurochir (Wien). 2011 Feb; 153(2):421-3.
    View in: PubMed
    Score: 0.016
  29. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery. 2009 Mar; 64(3):436-45; discussion 445-6.
    View in: PubMed
    Score: 0.014
  30. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery. 2008 Oct; 63(4):782-9; discussion 789.
    View in: PubMed
    Score: 0.014
  31. Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery. 2008 Oct; 63(4):790-7; discussion 797-8.
    View in: PubMed
    Score: 0.014
  32. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2006 Dec; 59(6):1278-84; discussion 1284-5.
    View in: PubMed
    Score: 0.012
  33. The Infundibulum-Aneurysm Conundrum: A Longitudinal Single-Center Analysis. AJNR Am J Neuroradiol. 2026 Aug 03; 47(8):2090-2099.
    View in: PubMed
    Score: 0.012
  34. Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy. Stroke Vasc Neurol. 2025 12 23; 10(6):734-742.
    View in: PubMed
    Score: 0.011
  35. Recurrent somatic copy number alterations in resected cerebral cavernous malformations. Hum Genomics. 2025 12 09; 20(1):12.
    View in: PubMed
    Score: 0.011
  36. A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromise. Acta Neuropathol Commun. 2025 09 24; 13(1):195.
    View in: PubMed
    Score: 0.011
  37. Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE III. Neurocrit Care. 2026 02; 44(1):261-272.
    View in: PubMed
    Score: 0.011
  38. Association of Quality of Life Domains and Clinical Symptoms in Patients With Familial Cerebral Cavernous Malformation. J Am Heart Assoc. 2025 09 02; 14(17):e035926.
    View in: PubMed
    Score: 0.011
  39. Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial. CNS Drugs. 2025 09; 39(9):865-877.
    View in: PubMed
    Score: 0.011
  40. Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations. Neurosurgery. 2005 Feb; 56(2):343-54.
    View in: PubMed
    Score: 0.011
  41. Multiple spinal cavernous malformations with atypical phenotype after prior irradiation: case report. Neurosurgery. 2004 Dec; 55(6):1431.
    View in: PubMed
    Score: 0.010
  42. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. J Neurol Neurosurg Psychiatry. 2024 09 17; 95(10):892-898.
    View in: PubMed
    Score: 0.010
  43. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 08 27; 9(4):446-456.
    View in: PubMed
    Score: 0.010
  44. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arterioscler Thromb Vasc Biol. 2024 06; 44(6):1246-1264.
    View in: PubMed
    Score: 0.010
  45. Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis. 2024 Jul; 33(7):107699.
    View in: PubMed
    Score: 0.010
  46. Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 03; 55(3):541-547.
    View in: PubMed
    Score: 0.010
  47. Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III. Neurocrit Care. 2024 06; 40(3):1140-1150.
    View in: PubMed
    Score: 0.010
  48. Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial. Neurosurgery. 2024 02 01; 94(2):334-339.
    View in: PubMed
    Score: 0.010
  49. Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
    View in: PubMed
    Score: 0.010
  50. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003 Feb; 52(2):465-77; discussion 477-8.
    View in: PubMed
    Score: 0.009
  51. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol. 2022 09 01; 79(9):856-868.
    View in: PubMed
    Score: 0.009
  52. Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. Stroke. 2022 06; 53(6):1847-1853.
    View in: PubMed
    Score: 0.009
  53. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery. 2002 Jan; 50(1):110-5; discussion 115-6.
    View in: PubMed
    Score: 0.009
  54. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Netw Open. 2021 12 01; 4(12):e2135773.
    View in: PubMed
    Score: 0.009
  55. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. J Magn Reson Imaging. 2022 05; 55(5):1440-1449.
    View in: PubMed
    Score: 0.008
  56. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
    View in: PubMed
    Score: 0.008
  57. Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery. 2001 Sep; 49(3):671-9; discussion 679-80.
    View in: PubMed
    Score: 0.008
  58. CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial. J Neuroinflammation. 2021 Aug 21; 18(1):179.
    View in: PubMed
    Score: 0.008
  59. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
    View in: PubMed
    Score: 0.008
  60. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021 06; 594(7862):271-276.
    View in: PubMed
    Score: 0.008
  61. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage. Sci Immunol. 2021 02 19; 6(56).
    View in: PubMed
    Score: 0.008
  62. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery. 2001 Feb; 48(2):359-67; discussion 367-8.
    View in: PubMed
    Score: 0.008
  63. Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
    View in: PubMed
    Score: 0.008
  64. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
    View in: PubMed
    Score: 0.008
  65. A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. JAMA Neurol. 2020 Nov 01; 77(11):1390-1397.
    View in: PubMed
    Score: 0.008
  66. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med. 2020 10 05; 217(10).
    View in: PubMed
    Score: 0.008
  67. Intraoperative endovascular treatment as an adjunct to microsurgical clipping of paraclinoid aneurysms. J Neurosurg. 2000 Oct; 93(4):554-60.
    View in: PubMed
    Score: 0.008
  68. Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution. J Neurosurg. 2000 Oct; 93(4):569-80.
    View in: PubMed
    Score: 0.008
  69. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
    View in: PubMed
    Score: 0.008
  70. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu. J Autoimmun. 2020 09; 113:102469.
    View in: PubMed
    Score: 0.008
  71. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance. J Neurosurg. 2021 03 01; 134(3):1147-1154.
    View in: PubMed
    Score: 0.008
  72. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020 04 01; 48(4):E12.
    View in: PubMed
    Score: 0.008
  73. Carotid endarterectomy prevention strategies and complications management. Neurosurg Clin N Am. 2000 Apr; 11(2):351-64.
    View in: PubMed
    Score: 0.008
  74. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
    View in: PubMed
    Score: 0.008
  75. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery. 2000 Jan; 46(1):28-35; discussion 35-6.
    View in: PubMed
    Score: 0.007
  76. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
    View in: PubMed
    Score: 0.007
  77. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. Crit Care Med. 2019 08; 47(8):1125-1134.
    View in: PubMed
    Score: 0.007
  78. Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight. 2019 06 20; 4(12).
    View in: PubMed
    Score: 0.007
  79. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554.
    View in: PubMed
    Score: 0.007
  80. De novo development of a cavernous malformation of the spinal cord following spinal axis radiation. Case report. J Neurosurg. 1999 Apr; 90(2 Suppl):234-8.
    View in: PubMed
    Score: 0.007
  81. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
    View in: PubMed
    Score: 0.007
  82. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery. 1999 Feb; 44(2):280-7; discussion 287-8.
    View in: PubMed
    Score: 0.007
  83. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
    View in: PubMed
    Score: 0.007
  84. Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage. Neurocrit Care. 2018 10; 29(2):180-188.
    View in: PubMed
    Score: 0.007
  85. Occipital lobe vascular malformations: prevalence of visual field deficits and prognosis after therapeutic intervention. Neurosurgery. 1998 Sep; 43(3):415-21; discussion 421-3.
    View in: PubMed
    Score: 0.007
  86. Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Surg Neurol. 1998 Aug; 50(2):147-55; discussion 155-6.
    View in: PubMed
    Score: 0.007
  87. The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32.
    View in: PubMed
    Score: 0.007
  88. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
    View in: PubMed
    Score: 0.007
  89. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10; 89(15):1553-1560.
    View in: PubMed
    Score: 0.006
  90. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology. 2017 Jul 25; 89(4):355-362.
    View in: PubMed
    Score: 0.006
  91. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke. 1997 Jun; 28(6):1130-7.
    View in: PubMed
    Score: 0.006
  92. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017 05 18; 545(7654):305-310.
    View in: PubMed
    Score: 0.006
  93. Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 2017; 43(5-6):223-230.
    View in: PubMed
    Score: 0.006
  94. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611.
    View in: PubMed
    Score: 0.006
  95. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237.
    View in: PubMed
    Score: 0.006
  96. Endovascular therapeutic approach to peripheral aneurysms of the superior cerebellar artery. AJNR Am J Neuroradiol. 1996 Aug; 17(7):1338-42.
    View in: PubMed
    Score: 0.006
  97. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery. 1996 Jun; 38(6):1265-71.
    View in: PubMed
    Score: 0.006
  98. Giant aneurysms of the anterior circle of Willis: management outcome of open microsurgical treatment. Surg Neurol. 1996 May; 45(5):409-20; discussion 420-1.
    View in: PubMed
    Score: 0.006
  99. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016 Apr 07; 532(7597):122-6.
    View in: PubMed
    Score: 0.006
  100. Galen's anecdote of the fallen sophist: on the certainty of science through anatomy. J Neurosurg. 1995 Nov; 83(5):929-32.
    View in: PubMed
    Score: 0.006
  101. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
    View in: PubMed
    Score: 0.006
  102. Intracarotid amobarbital procedure as a predictor of material-specific memory change after anterior temporal lobectomy. Epilepsia. 1995 Sep; 36(9):857-65.
    View in: PubMed
    Score: 0.006
  103. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6620-4.
    View in: PubMed
    Score: 0.005
  104. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301.
    View in: PubMed
    Score: 0.005
  105. Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care. 2014 Dec; 21(3):426-34.
    View in: PubMed
    Score: 0.005
  106. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014 Jul; 49(7):498-504.
    View in: PubMed
    Score: 0.005
  107. DBS reduced hemichorea associated with a developmental venous anomaly and microbleeding in STN. Neurology. 2014 Feb 18; 82(7):636-7.
    View in: PubMed
    Score: 0.005
  108. Radiosurgery and venous malformations. J Neurosurg. 1994 Jan; 80(1):171-3; author reply 174-5.
    View in: PubMed
    Score: 0.005
  109. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain. Observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke. 1993 Sep; 24(9):1339-46.
    View in: PubMed
    Score: 0.005
  110. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
    View in: PubMed
    Score: 0.005
  111. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
    View in: PubMed
    Score: 0.005
  112. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34.
    View in: PubMed
    Score: 0.005
  113. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41.
    View in: PubMed
    Score: 0.005
  114. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.004
  115. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
    View in: PubMed
    Score: 0.004
  116. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8.
    View in: PubMed
    Score: 0.004
  117. Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg. 2013 Jul-Aug; 80(1-2):89-93.
    View in: PubMed
    Score: 0.004
  118. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
    View in: PubMed
    Score: 0.004
  119. A new class of electrodes of 'intermediate invasiveness': preliminary experience with epidural pegs and foramen ovale electrodes in the mapping of seizure foci. Neurol Res. 1991 Sep; 13(3):177-83.
    View in: PubMed
    Score: 0.004
  120. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
    View in: PubMed
    Score: 0.004
  121. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. Genet Med. 2011 Jul; 13(7):662-6.
    View in: PubMed
    Score: 0.004
  122. Second operation after the failure of previous resection for epilepsy. Neurosurgery. 1991 Apr; 28(4):510-8.
    View in: PubMed
    Score: 0.004
  123. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011 Mar; 68(3):641-7; discussion 647-8.
    View in: PubMed
    Score: 0.004
  124. Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia. 1991 Mar-Apr; 32(2):179-86.
    View in: PubMed
    Score: 0.004
  125. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.004
  126. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990 Jun; 72(6):839-50.
    View in: PubMed
    Score: 0.004
  127. Neurological deterioration in a patient with a spinal arteriovenous malformation following lumbar puncture. Case report. J Neurosurg. 1990 Apr; 72(4):650-3.
    View in: PubMed
    Score: 0.004
  128. Alcohol histories in hospital: does the age and sex of the patient make a difference? Br J Addict. 1990 Jan; 85(1):149-50.
    View in: PubMed
    Score: 0.004
  129. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery. 2009 Jul; 65(1):138-44; discussion 144-5.
    View in: PubMed
    Score: 0.004
  130. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery. 1989 Apr; 24(4):557-60.
    View in: PubMed
    Score: 0.004
  131. Genomics of human intracranial aneurysm wall. Stroke. 2009 Apr; 40(4):1252-61.
    View in: PubMed
    Score: 0.004
  132. Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block. Br J Anaesth. 2008 Oct; 101(4):549-56.
    View in: PubMed
    Score: 0.003
  133. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105:217-20.
    View in: PubMed
    Score: 0.003
  134. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987 Mar-Apr; 18(2):365-72.
    View in: PubMed
    Score: 0.003
  135. Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups. Neurosurgery. 1987 Feb; 20(2):222-7.
    View in: PubMed
    Score: 0.003
  136. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986 Nov-Dec; 17(6):1090-7.
    View in: PubMed
    Score: 0.003
  137. Current updates in perioperative management of intracerebral hemorrhage. Neurol Clin. 2006 Nov; 24(4):745-64.
    View in: PubMed
    Score: 0.003
  138. Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study. Neurosurgery. 1986 Oct; 19(4):655-64.
    View in: PubMed
    Score: 0.003
  139. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery. 1986 Aug; 19(2):247-51.
    View in: PubMed
    Score: 0.003
  140. [Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
    View in: PubMed
    Score: 0.003
  141. Focal parenchymal lesions in transient ischemic attacks: correlation of computed tomography and magnetic resonance imaging. Stroke. 1986 May-Jun; 17(3):399-403.
    View in: PubMed
    Score: 0.003
  142. Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: technical case report. Neurosurgery. 2005 Mar; 56(3):E626; discussion E626.
    View in: PubMed
    Score: 0.003
  143. Nocardial osteomyelitis of the spine with epidural spinal cord compression--a case report. Neurosurgery. 1984 Aug; 15(2):254-6.
    View in: PubMed
    Score: 0.003
  144. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984 Apr; 60(4):771-6.
    View in: PubMed
    Score: 0.003
  145. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.002
  146. Correlation of clinical and angiographic findings in brain ischemia with regional cerebral blood flow measured by the xenon inhalation technique. Neurosurgery. 1982 Jul; 11(1 Pt 1):1-5.
    View in: PubMed
    Score: 0.002
  147. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001 Jun; 32(6):1458-71.
    View in: PubMed
    Score: 0.002
  148. A quality-of-life instrument for young hemorrhagic stroke patients. Stroke. 2001 Mar; 32(3):687-95.
    View in: PubMed
    Score: 0.002
  149. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000 Jun; 46(6):1454-9.
    View in: PubMed
    Score: 0.002
  150. Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
    View in: PubMed
    Score: 0.002
  151. Hemorrhagic lesion at the tentorial incisura in a patient with facial nevus. Neurosurgery. 1999 Nov; 45(5):1216-21.
    View in: PubMed
    Score: 0.002
  152. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998 Nov; 7(12):1851-8.
    View in: PubMed
    Score: 0.002
  153. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol. 1996 Oct; 17(9):1733-42.
    View in: PubMed
    Score: 0.001
  154. Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions. Stroke. 1996 Sep; 27(9):1558-63.
    View in: PubMed
    Score: 0.001
  155. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery. 1996 Sep; 39(3):537-45; discussion 545-7.
    View in: PubMed
    Score: 0.001
  156. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996 May; 38(5):915-24; discussion 924-5.
    View in: PubMed
    Score: 0.001
  157. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996 Apr 11; 334(15):946-51.
    View in: PubMed
    Score: 0.001
  158. Ischemic stroke and intracranial multifocal cerebral arteriopathy in Williams syndrome. J Pediatr. 1995 Jun; 126(6):945-8.
    View in: PubMed
    Score: 0.001
  159. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res. 1995 Feb; 17(1):49-58.
    View in: PubMed
    Score: 0.001
  160. Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. Electroencephalogr Clin Neurophysiol. 1994 Sep; 91(3):179-93.
    View in: PubMed
    Score: 0.001
  161. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr; 191(1):33-9.
    View in: PubMed
    Score: 0.001
  162. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993 Oct; 33(4):547-54; discussion 554-5.
    View in: PubMed
    Score: 0.001
  163. Comparison and spacial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy. Neurol Res. 1993 Jun; 15(3):160-8.
    View in: PubMed
    Score: 0.001
  164. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
    View in: PubMed
    Score: 0.001
  165. Differences of in vitro electrophysiology of hippocampal neurons from epileptic patients with mesiotemporal sclerosis versus structural lesions. Epilepsia. 1992 Jul-Aug; 33(4):601-9.
    View in: PubMed
    Score: 0.001
  166. Multiple vertebral hemangiomas with neurological signs. Case report. J Neurosurg. 1992 Jun; 76(6):1025-8.
    View in: PubMed
    Score: 0.001
  167. Natural history of recurrent seizures after resective surgery for epilepsy. Epilepsia. 1991 Nov-Dec; 32(6):851-6.
    View in: PubMed
    Score: 0.001
  168. Intracarotid amobarbital procedure: I. Prediction of decreased modality-specific memory scores after temporal lobectomy. Epilepsia. 1991 Nov-Dec; 32(6):857-64.
    View in: PubMed
    Score: 0.001
  169. Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
    View in: PubMed
    Score: 0.001
  170. Reversal of a dense, persistent, holohemispheric neurological deficit after an endarterectomy of the carotid artery: case report. Neurosurgery. 1991 Aug; 29(2):261-4.
    View in: PubMed
    Score: 0.001
  171. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  172. Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery. 1991 May; 28(5):639-45.
    View in: PubMed
    Score: 0.001
  173. Surgical management of syringomyelia: a five year experience in the era of magnetic resonance imaging. Neurol Res. 1991 Mar; 13(1):3-9.
    View in: PubMed
    Score: 0.001
  174. Delayed facial nerve palsy after temporal lobectomy for epilepsy: report of four cases and discussion of possible mechanisms. Neurosurgery. 1991 Mar; 28(3):453-6.
    View in: PubMed
    Score: 0.001
  175. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990 May; 27(5):474-9.
    View in: PubMed
    Score: 0.001
  176. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986 Oct; 20(4):502-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.